![]() |
|
|
Vol. 61, Issue 3, 628-636, March 2002
Institutes of Pharmacology (E.B.-L., C.C., B.N.) and Pharmacy
(E.B.-L., R.S., W.S.), Berlin Free University, Berlin, Germany;
Institute of Pharmacology, University of Vienna, Vienna, Austria (O.K.,
M.F.); Department of Pharmacology and Toxicology, University of Ulm,
Ulm, Germany (B.N.)
We have previously shown that alkyl-substituted amino acid derivatives
directly activate Gi/o proteins.
N-Dodecyl-N
,N
-(bis-l-lysinyl)-l-lysine
amide (FUB132) is a new representative of this class of compounds with
increased efficacy. Here, we characterized the molecular mechanism of
action of this class of compounds. FUB132 and its predecessor FUB86
were selective receptomimetics for Gi/o
because they stimulated the guanine nucleotide exchange reaction of
purified Gi/o as documented by an increased rate of GDP
release, GTP
S binding, and GTP hydrolysis. In contrast to the
receptomimetic peptide mastoparan, stimulation of G proteins by
lipoamines required the presence of neither G
-dimers nor lipids.
On the contrary, G
-dimers suppressed the stimulatory effect of
FUB132. The stimulation of Gi/o by lipoamines and by mastoparan was not additive. A peptide derived from the C terminus of
G
o3, but not a corresponding G
q-derived
peptide, quenched the FUB132-induced activation of G
o.
In membranes prepared from human embryonic kidney 293 cells that stably
expressed the Gi/o-coupled human A1-adenosine
receptor, lipoamines impeded high-affinity agonist binding. In
contrast, antagonist binding was not affected. We conclude that
alkyl-substituted amines target a site, most likely at the C terminus
of G
i/o-subunits, that is also contacted by receptors.
However, because G
-dimers blunt rather than enhance their
efficacy, their mechanism of action differs fundamentally from that of
a receptor. Thus, despite their receptomimetic effect in vitro,
alkyl-substituted amines and related polyamines are poor direct G
protein activators in vivo. In the presence of G
, they rather
antagonize G protein-coupled receptor signaling.
This article has been cited by other articles:
![]() |
G. P. Prevost, M. O. Lonchampt, S. Holbeck, S. Attoub, D. Zaharevitz, M. Alley, J. Wright, M. C. Brezak, H. Coulomb, A. Savola, et al. Anticancer Activity of BIM-46174, a New Inhibitor of the Heterotrimeric G{alpha}/G{beta}{gamma} Protein Complex. Cancer Res., September 15, 2006; 66(18): 9227 - 9234. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Nanoff, R. Koppensteiner, Q. Yang, E. Fuerst, H. Ahorn, and M. Freissmuth The Carboxyl Terminus of the G{alpha}-Subunit Is the Latch for Triggered Activation of Heterotrimeric G Proteins Mol. Pharmacol., January 1, 2006; 69(1): 397 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Skokowa, S. R. Ali, O. Felda, V. Kumar, S. Konrad, N. Shushakova, R. E. Schmidt, R. P. Piekorz, B. Nurnberg, K. Spicher, et al. Macrophages Induce the Inflammatory Response in the Pulmonary Arthus Reaction through G{alpha}i2 Activation That Controls C5aR and Fc Receptor Cooperation J. Immunol., March 1, 2005; 174(5): 3041 - 3050. [Abstract] [Full Text] [PDF] |
||||